약물감시 시장 : 임상시험 단계별, 방법 유형별, 서비스 제공업체 유형별, 지역별
Pharmacovigilance Market, By Clinical Trial Phases, By Type of Method, By Type of Service Provider, By Geography
상품코드
:
1672731
리서치사
:
Coherent Market Insights
발행일
:
2025년 02월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계의 약물감시 시장은 2025년에 80억 3,000만 달러를 기록할 것으로 추정됩니다. 2032년에는 140억 3,000만 달러에 이를 것으로 예측되며, 2025-2032년까지의 연평균 성장률(CAGR)은 8.3%를 나타낼 것으로 전망됩니다.
| 보고 범위 |
보고서 세부정보 |
| 기준 연도 |
2024년 |
2025년 시장 규모 |
80억 3,000만 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측 기간(2025-2032년) CAGR |
8.30% |
2032년 금액 예측 |
140억 3,000만 달러 |
그림. 약물감시 시장 점유율(%), 2025년, 지역별
세계의 약물감시 시장은 최근 몇 년간 현저한 성장을 이루고 있습니다. Pharmacovisiliance는 부작용 및 기타 약물 관련 문제의 검출, 평가, 이해 및 예방에 관한 과학 및 활동으로 정의됩니다. 의약품 분자가 복잡해지고 새로운 치료법이 시장에 도입됨에 따라 판매 후 의약품의 안전성을 효과적으로 모니터링 할 필요성이 커지고 있습니다. 의약품의 안전성 모니터링을 의무화하는 엄격한 규제 프레임워크은 부작용이 증가함에 따라 약물감시 서비스 수요를 세계적으로 밀어 올리고 있습니다. 게다가 제네릭 의약품 시장의 확대와 신흥 지역에 대한 임상시험의 아웃소싱은 약물감시 시장을 더욱 밀어 올리고 있습니다.
시장 역학
세계의 약물감시 시장은 의약품 부작용 증가, 의약품 승인을 위한 엄격한 안전 규제, 효율적인 치료법에 대한 수요 증가, 제네릭 의약품 시장 확대에 의해 견인되고 있습니다. 시판 후 조사를 의무화하는 엄격한 규제 가이드라인은 약물감시 서비스 수요를 증대시키는 주요 요인입니다. 게다가 안전성 문제로 인한 의약품 회수 동향이 증가함에 따라 제약회사는 약물감시 업무를 전문 서비스 제공업체에 위탁할 수 없게 되었습니다. 게다가 선진국에서 제네릭 의약품 시장의 확대는 약물감시 시장의 진출기업에 큰 기회를 제공합니다. 그러나 중견·중소제약기업의 예산상의 제약과 지역간의 의약품안전성 데이터의 보고의 복잡성이 시장 진입기업에 과제를 집중하고 있습니다.
본 조사의 주요 특징
- 본 보고서는 세계의 약물감시 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간(2025-2032년) 시장 규모(10억 달러)와 복합연간 성장률(CAGR%)을 제공합니다.
- 또한 다양한 부문에 걸친 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 출시 및 승인, 시장 동향, 지역에 의한 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
- 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 매개변수를 기반으로 세계의 약물감시 시장 주요 기업을 프로파일링합니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 타이핑, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
- 세계의 약물감시 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 산업의 다양한 이해관계자들에 대응하고 있습니다.
- 이해관계자들은 세계의 약물감시 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.
목차
제1장 조사의 목적과 전제조건
제2장 시장 전망
- 보고서 설명
- 주요 요약
- Coherent Opportunity Map (COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 영향 분석
- 시장 동향
- 규제 시나리오
- 인수 및 제휴 시나리오
- 자금 조달 및 투자
- PEST 분석
- Porter's Five Forces 분석
제4장 세계의 약물감시 시장 - 코로나바이러스(COVID-19)팬데믹의 영향
- 전체적인 영향
- 정부의 대처
- COVID-19에 의한 시장에 대한 영향
제5장 세계의 약물감시 시장, 임상시험 단계별(2020-2032년), 10억 달러
- 서론
- 전임상 연구
- 임상시험 단계 I
- 임상시험 단계 II
- 임상시험 단계 III
- 시판 후 감시 또는 단계 IV
제6장 세계의 약물감시 시장, 방법 유형별(2020-2032년), 10억 달러
- 서론
- 자발적 보고
- 강화된 ADR 보고
- 표적 보고
- 코호트 이벤트 모니터링
- EHR 모니터링
제7장 세계의 약물감시 시장, 서비스 제공업체 유형별(2020-2032년), 10억 달러
제8장 세계의 약물감시 시장, 지역별(2020-2032년), 10억 달러
- 서론
- 북미
- 라틴아메리카
- 유럽
- 아시아태평양
- 중동
- 아프리카
제9장 경쟁 구도
- 기업 프로파일
- Accenture
- Cognizant Technology Solutions
- Laboratory Corporation of America Holdings(LabCorp)
- IBM Corporation
- QuintilesIMS(IQVIA)
- ICON plc
- Capgemini
- ITClinical
- TAKE Solutions Ltd
- BioClinica
- PAREXEL International Corporation
- Wipro Ltd
- FMD K&L
- Linical Accelovance
- United BioSource Corporation(UBC)
- PRA Health Sciences
- ArisGlobal
- Ennov Solutions Inc
제10장 애널리스트 추천
제11장 참고문헌과 조사방법
KTH
영문 목차
Global Pharmacovigilance Market is estimated to be valued at USD 8.03 Bn in 2025 and is expected to reach USD 14.03 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.3% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 8.03 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
8.30% |
2032 Value Projection: |
USD 14.03 Bn |
Figure. Pharmacovigilance Market Share (%), By Region 2025
The global pharmacovigilance market has been witnessing significant growth in the recent years. Pharmacovigilance is defined as the science and activities relating to the detection, assessment, understanding, prevention of adverse effects or any other drug-related problems. With the growing complexity of drug molecules and the introduction of novel therapies in the market, there is an increasing need to effectively monitor the safety of drugs post marketing. Stringent regulatory framework mandating drug safety monitoring along with increasing instances of adverse drug reactions is propelling the demand for pharmacovigilance services across the globe. Furthermore, the expanding generics market and outsourcing of clinical trials to emerging regions has further boosted the pharmacovigilance market.
Market Dynamics:
The global pharmacovigilance market is driven by the rising number of adverse drug reactions, stringent safety regulations for drug approval, increasing demand for efficacious therapies, and growing generics market. Stringent regulatory guidelines mandating post marketing surveillance is a key factor augmenting the demand for pharmacovigilance services. Furthermore, rising trend of drug recalls due to safety issues has compelled pharmaceutical companies to outsource their pharmacovigilance activities to specialized service providers. Moreover, increasing generics market in developed countries offer significant opportunities for the pharmacovigilance market players. However, budget constraints of small and midsize pharmaceutical companies and complexity of reporting drug safety data across regions pose challenges to market players.
Key Features of the Study:
- This report provides in-depth analysis of the global pharmacovigilance market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global pharmacovigilance market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Accenture, Cognizant, Laboratory Corporation of America Holdings, IBM Corporation, ArisGlobal, ICON plc., Capgemini, ITClinical, FMD K&L, and IQVIA
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global pharmacovigilance market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmacovigilance market
Detailed Segmentation-
- By Clinical Trial Phases
- Total Knee Replacement
- Partial Knee Replacement
- Kneecap Replacement
- Revision Knee Replacement
- By Type of Method
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Reporting
- Cohort Event Monitoring
- EHR Monitoring
- By Type of Service Provider
- In-House
- Contract Outsourcing
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Accenture
- Cognizant Technology Solutions
- Laboratory Corporation of America Holdings (LabCorp)
- IBM Corporation
- QuintilesIMS (IQVIA)
- ICON plc
- Capgemini
- ITClinical
- TAKE Solutions Ltd
- BioClinica
- PAREXEL International Corporation
- Wipro Ltd
- FMD K&L
- Linical Accelovance
- United BioSource Corporation (UBC)
- PRA Health Sciences
- ArisGlobal
- Ennov Solutions Incc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Clinical Trial Phases
- Market Snapshot, By Type of Method
- Market Snapshot, By Type of Service Provider
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Pharmacovigilance Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Pharmacovigilance Market, By Clinical Trial Phases, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Pre-clinical Studies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Clinical Trial Phase I
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Clinical Trial Phase II
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Clinical Trial Phase III
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Post Marketing Surveillance or Phase IV
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Pharmacovigilance Market, By Type of Method, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Spontaneous Reporting
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Intensified ADR Reporting
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Targeted Reporting
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cohort Event Monitoring
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- EHR Monitoring
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Pharmacovigilance Market, By Type of Service Provider, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- In-House
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Contract Outsourcing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Pharmacovigilance Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Accenture
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cognizant Technology Solutions
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Laboratory Corporation of America Holdings (LabCorp)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- IBM Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- QuintilesIMS (IQVIA)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ICON plc
- Capgemini
- ITClinical
- TAKE Solutions Ltd
- BioClinica
- PAREXEL International Corporation
- Wipro Ltd
- FMD K&L
- Linical Accelovance
- United BioSource Corporation (UBC)
- PRA Health Sciences
- ArisGlobal
- Ennov Solutions Inc
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About Us and Sales Contact
관련자료
